ACTRN12619001109190已完成未知
Investigation of AcrySof IQ Panoptix Presbyopia Correcting IOL for subjects with mild to moderate astigmatism
Alcon Laboratories0 个研究点目标入组 12 人开始时间: 2019年8月12日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 40 Years 至 o limit(—)
- 性别
- All
入选标准
- •Subjects are eligible for the study if they meet the following criteria:
- •Note: Ocular criteria must be met in both eyes.
- •- are more than 40 years of age, of either gender and any race;
- •- have completed uncomplicated cataract surgery or refractive lens exchange surgery with the Alcon Panoptix Toric IOL at least 6 months prior (but no greater than 12 months)
- •- regular corneal astigmatism requiring toric IOL correction
排除标准
- •If any of the following exclusion criteria are applicable to the subject or either eye, the subject should not be enrolled in the study.
- •- Amblyopia
- •- Previous anterior or posterior chamber surgery (e.g., vitrectomy, laser iridotomy)
- •- Diabetic retinopathy
- •- Macular degeneration
- •- History of retinal detachment
- •- Subjects who have an acute or chronic disease or illness that would confound the results of this investigation (e.g., immunocompromised, connective tissue disease, clinically significant atopic disease, diabetes, and any other such disease or illness), that are known to affect post-operative visual acuity.
研究者
相似试验
已完成
4 期
Investigation of the AcrySof® IQ PanOptix* Presbyopia Correcting IOL Model TFNT0010047518PresbyopiaNL-OMON44109Alcon Laboratories10
已完成
不适用
Investigation of AcrySof® IQ PanOptix™ Presbyopia-Correcting Intraocular Lens (IOL) Model TFNT00CataractNCT02529488Alcon Research167
已完成
不适用
Clinical Investigation of AcrySof® IQ PanOptix™ IOL Model TFNT00CataractNCT03280108Alcon Research250
已完成
不适用
Clinical Investigation of the AcrySof® IQ PanOptix™ IOLCataractNCT03090256Alcon Research76
招募中
不适用
Clinical outcomes of AcrySof IQ Vivity intraocular lens in patients with age-related macular degeneration after cataract surgeryEyes operated by cararact surgeryDRKS00030673Promoter's representative of OFTALVIST (Oftalmología Vistahermosa, SL)25
